Accord Plasma B.V. Expands Global Plasma Therapy Capabilities with Acquisition of Prothya Biosolutions
LONDON, Oct. 20, 2025 /PRNewswire/ -- Accord Plasma B.V., a subsidiary of Intas…
Dun & Bradstreet Showcases India’s Strategic Edge at the GCC Summit 2025
MUMBAI, India, Oct. 16, 2025 /PRNewswire/ -- Dun & Bradstreet, a leading…
ServiceTrade Launches Grow Your Own Technician Workforce Program with VSC Fire & Security and Durham Tech
$5,000 grant will underwrite a new apprentice hire and training; the program…
WePlay x Care Bears Halloween Carnival Party Officially Kicks Off!
WASHINGTON, Oct. 19, 2025 (GLOBE NEWSWIRE) -- As Halloween night falls, WePlay teams…
How grass from China is changing lives in Fiji
GUANGZHOU, China, Oct. 16, 2025 /PRNewswire/ -- News report from GDToday: In Fiji,…
How leaming Chinese becomes a new trend in Fiji
GUANGZHOU, China, Oct. 16, 2025 /PRNewswire/ -- News report from GDToday: In…
Wialon Announces Top 10 GPS Hardware Manufacturers for 2025
DUBAI, UAE, Oct. 19, 2025 /PRNewswire/ -- Teltonika Telematics has once again been…
Manipal Hospital Sarjapur Road Empowers Fitness Enthusiasts with CPR Skills and First-Aid Workshop
BENGALURU, India, Oct. 14, 2025 /PRNewswire/ -- With the growing emphasis on…
Improving Public Health in the Global South by Leveraging Innovative Smoke-free Alternatives, focus at Technovation’25
NEW DELHI, Oct. 14, 2025 /PRNewswire/ -- Philip Morris International (PMI) recently hosted…
Subcutaneous RYBREVANT(amivantamab) delivers promising 45 percent overall response rate with median duration of response of 7.2 months in recurrent or metastatic head and neck cancer
Responses were rapid and durable, and tumour shrinkage was observed in 82…